Cytek Biosciences (CTKB) Work In Process (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Work In Process data on file, last reported at $16.3 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 155.62% year-over-year to $16.3 million; the trailing twelve-month figure through Mar 2026 stood at $16.3 million (up 155.62% YoY), and the FY2025 full-year result was $16.5 million, up 154.79% from the prior year.
• Work In Process for Q1 2026 stood at $16.3 million, down from $16.5 million in the prior quarter.
• Across five years, Work In Process topped out at $16.5 million in Q4 2025 and bottomed at $1.5 million in Q1 2022.
• The 5-year median for Work In Process is $6.3 million (2024), against an average of $7.4 million.
• The widest annual swing landed in 2023, when Work In Process jumped 201.39%; it then sank 48.56% in 2024.
• A 5-year view of Work In Process shows it stood at $4.9 million in 2022, then soared by 113.48% to $10.5 million in 2023, then tumbled by 37.94% to $6.5 million in 2024, then soared by 154.79% to $16.5 million in 2025, then decreased by 1.16% to $16.3 million in 2026.
• The last three Work In Process figures came in at $16.3 million (Q1 2026), $16.5 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.

Peer Comparison